Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity
March 6, 2025
INmune Bio, Inc. Highlights INKmune(TM) Data Featured in NK Cells in Solid Tumors Workshop at Innate Killer Summit
April 4, 2022
Related Post
-
-
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
March 6, 2025
-
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
March 6, 2025
-
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
March 5, 2025